Equities research analysts at DA Davidson began coverage on shares of Nature's Sunshine Products (NASDAQ:NATR - Get Free Report) in a research note issued to investors on Wednesday. The brokerage set a "buy" rating and a $19.00 price target on the stock. DA Davidson's price target would suggest a potential upside of 37.68% from the stock's previous close.
Nature's Sunshine Products Trading Down 3.6 %
Nature's Sunshine Products stock traded down $0.52 during midday trading on Wednesday, hitting $13.80. The stock had a trading volume of 63,627 shares, compared to its average volume of 48,712. The business has a fifty day moving average price of $12.57 and a 200 day moving average price of $14.04. Nature's Sunshine Products has a 12 month low of $10.81 and a 12 month high of $18.06. The stock has a market cap of $255.08 million, a P/E ratio of 15.68 and a beta of 1.10.
Nature's Sunshine Products (NASDAQ:NATR - Get Free Report) last issued its quarterly earnings results on Tuesday, May 6th. The company reported $0.25 earnings per share for the quarter, beating analysts' consensus estimates of $0.16 by $0.09. Nature's Sunshine Products had a return on equity of 11.08% and a net margin of 3.81%. The business had revenue of $113.25 million during the quarter, compared to the consensus estimate of $109.39 million.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently modified their holdings of NATR. GAMMA Investing LLC boosted its stake in Nature's Sunshine Products by 2,090.2% in the first quarter. GAMMA Investing LLC now owns 2,234 shares of the company's stock valued at $28,000 after acquiring an additional 2,132 shares during the period. Russell Investments Group Ltd. bought a new stake in shares of Nature's Sunshine Products in the 4th quarter worth approximately $41,000. Amundi bought a new stake in shares of Nature's Sunshine Products in the 4th quarter worth approximately $63,000. Deutsche Bank AG bought a new position in Nature's Sunshine Products during the 4th quarter worth $103,000. Finally, Wells Fargo & Company MN increased its position in Nature's Sunshine Products by 28.8% in the fourth quarter. Wells Fargo & Company MN now owns 7,209 shares of the company's stock worth $106,000 after buying an additional 1,611 shares during the period. 79.40% of the stock is owned by institutional investors and hedge funds.
Nature's Sunshine Products Company Profile
(
Get Free Report)
Nature's Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.
Featured Articles
Before you consider Nature's Sunshine Products, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nature's Sunshine Products wasn't on the list.
While Nature's Sunshine Products currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
